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Abstract
Introduction: In the World Health Organization histological classification of the liver tumor, peliosis hepatis is
defined as a tumor-like lesion. The entity is characterized by the appearance of multiple cyst-like, blood-filled spaces
within the liver parenchyma.
Case presentation: A 77-year-old Japanese man with prostate cancer was referred to our department because he
was diagnosed as having two hepatic tumors. The tumors were confirmed to be peliosis hepatis by repeated
needle biopsies and because of their atypical images by enhanced computed tomography and enhanced magnetic
resonance imaging. Later these tumors grew rapidly, increased in number, and disseminated throughout his whole
liver. We are now treating the patient conservatively due to his age and his existing medical conditions.
Conclusion: Peliosis hepatis is a rare hepatic benign tumor that should be considered in the differential diagnosis
of multiple unknown liver tumors that are revealed by atypical radiological images.
Introduction
When a patient presents with multiple liver tumors re-
vealed by atypical radiological images, a decision as to
whether liver needle biopsies are necessary must be
carefully made because needle biopsies can cause serious
complications [1]. In the World Health Organization
(WHO) histological classification of the liver tumor,
peliosis hepatis (PH) is defined as a tumor-like lesion.
The pathological entity is characterized by the appear-
ance of multiple cyst-like and blood-filled spaces within
the liver parenchyma [2, 3]. It is currently considered
that PH is related to human immunodeficiency virus
(HIV) infection [4], agents administered after kidney
transplantation [5], and the administration of oral con-
traceptives [6]. Here we report a case of PH that rapidly
disseminated throughout the whole liver in a patient
with prostate cancer.
Case presentation
A 77-year-old Japanese man was referred to our depart-
ment because he was diagnosed as having hepatic tu-
mors. His history included an old myocardial infarction,
obstructed arterial sclerosis of his bilateral lower feet,
and prostate cancer. In February 2010, he had a
luteinizing hormone-releasing hormone (LH-RH) agon-
ist injection and radiation therapy for prostate cancer for
1 year. In March 2012, he was found to have liver tu-
mors for the first time during a regular follow-up ab-
dominal ultrasonography.
He had no history of tobacco smoking or drinking alco-
hol and no family history of liver disease, hypertension, dia-
betes mellitus, or liver malignancy. He had been
asymptomatic; however, two liver tumors were shown in an
ultrasonographic examination image: 50×36mm in segment
(S) 7 and 30×18mm in S6 (Fig. 1a, b). We checked some
tumor markers including alpha-fetoprotein, des-gamma-
carboxy prothrombin, carcinoembryonic antigen, carbohy-
drate antigen 19-9, and prostate specific antigen, and they
were all within normal ranges (Table 1).
Hepatic dynamic computed tomography (CT) indi-
cated the presence of liver tumors (Fig. 2a–h). Both
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tumors were isodense before contrast injection (Fig. 2a, e) and
showed hypoenhancement in the arterial phase (Fig. 2b, f).
Afterward in the portal venous phase, the tumor in S7 showed
heterogeneous enhancement, and the tumor in S6 showed
central enhancement (Fig. 2c, g). Furthermore, in the delayed
phase, the tumor in S7 showedmore heterogeneous enhance-
ment, and the tumor in S6 showedmore central enhancement
(Fig. 2d, h). The abdominal magnetic resonance image (MRI)
showed hypointense tumors on the T1-weighted image (WI)
and hyperintense tumors on T2WI in both tumors (Fig. 3a, b,
e, and f). In the arterial phase of T1WI, the tumor in S7
showed heterointensity, but the tumor in S6 showed central
enhancement (Fig. 3c, g). Like the CT image, in the parenchy-
mal phase of T1WI, the tumor in S7 showed more heteroin-
tensity, and the tumor in S6 showed more central
enhancement (Fig. 3d, h). The differential diagnoses after CT
and MRI imaging examinations included metastatic liver
tumor, inflammatory pseudotumor, epithelioid hemangioen-
dothelioma, and hepatic angiosarcoma.
In June 2012, we carefully performed the first liver bi-
opsy because he had anticoagulation therapy for an old
myocardial infarction. Histological results showed
marked sinusoidal dilatation throughout the lobule with
cystic cavity formation. The endothelial cells lining these
spaces were flat, and no cellular atypia was identified.
Liver cell plates were rather atrophic. There was no evi-
dence of malignancy (Fig. 4a, b).
CD34 immunostaining was negative in the sinusoidal
endothelium (Fig. 4c). We were able to exclude the dif-
ferential diagnosis based on typical histological results
including CD34 immunostaining, which is a useful
marker to distinguish vascular tumors, such as hemangi-
omas, from PH [7]. We decided to treat him conserva-
tively with regular follow-ups.
Fig. 1 Abdominal ultrasonography shows two hepatic tumors in March 2012. a A high echoic tumor (50×36mm) with an unclear margin was
observed in segment 7 (white arrows). b A low echoic tumor (30×18mm) with a clear margin was observed in segment 6 (white arrowheads)
Table 1 Laboratory data on the first tumor biopsy
WBC 6,100 /μl Na 131 mEq/l
RBC 44,900 /μl K 4.8 mEq/l
Hb 13.9 g/dl Cl 93 mEq/l
Ht 40.1 % Ca 9.4 mg/dl
Plt 238,000 /μl BUN 16.3 mg/dl
PT-% >100 % Cr 0.84 mg/dl
TP 7.7 g/dl CRP <0.1 mg/dl
Alb 4.5 g/dl
T.Bil 0.8 mg/dl AFP 3.7 ng/ml
AST 18 IU/l DCP 18 mAU/ml
ALT 19 IU/l CEA 1.9 ng/ml
LDH 264 IU/l CA 19-9 6.9 U/ml
ALP 127 IU/l PSA 0.26 ng/ml
Gamma-GTP 68 IU/l
Glu 75 mg/dl HBsAg (–)
BUN 16.3 mg/dl HCV-Ab (–)
Cr 0.84 mg/dl
AFP alpha-fetoprotein, Alb albumin, ALP alkaline phosphatase, ALT alanine ami-
notransferase, AST aspartate aminotransferase, BUN blood urea nitrogen, Ca
calcium, CA 19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, Cl
chloride, Cr creatinine, CRP C-reactive protein, DCP des-gamma-carboxy pro-
thrombin, gamma-GTP gamma-glutamyl transpeptidase, Glu glucose, Hb
hemoglobin, HBsAg hepatitis B surface antigen; HCV-Ab hepatitis C virus anti-
bodies; Ht hematocrit; K potassium; LDH lactate dehydrogenase; Na sodium; Plt
platelet; PSA prostate specific antigen; PT-% prothrombin time percent; RBC
red blood cell; T.Bil total bilirubin; TP total protein; WBC white blood cell
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Afterward, these tumors grew rapidly, and the number
of tumors increased and disseminated throughout his
whole liver (Fig. 5a–c). He remained asymptomatic. In
July 2013, we performed a second tumor biopsy. The
histological findings were almost the same as those in
the previous biopsy. Although slight anisonucleosis and
chromatin increase of dilated sinusoids-lining endothe-
lium* were seen, there was no convincing evidence of
angiosarcoma (Fig. 6a, b). No CD34 expression was re-
vealed in the sinusoidal endothelium or in the previous
biopsy (Fig. 6c).
The patient was reconfirmed as having PH of the liver.
We treated him conservatively because he was relatively ad-
vanced in age in addition to having several confounding
diseases.
Discussion
To the best of our knowledge, this is the first report of a
case in which PH disseminated rapidly to the whole liver
in a patient with prostate cancer who had been treated
with an LH-RH agonist. PH is a benign tumor-like le-
sion; however, it is difficult to diagnose accurately with-
out a tumor biopsy because its clinical and radiological
characteristics are nonspecific [8].
Regarding the history of the PH diagnoses, in 1861,
Wagner first used the term, “pelios,” which in Greek
means blackish-bluish with contusion, to describe the
gross appearance of the lesions on the cut surface of the
liver [2]. Before the 1970s, PH was mainly diagnosed by
autopsy. It was later seen in patients with tuberculosis,
disseminated malignancies, and hematological disorders
Fig. 2 Abdominal computed tomography imaging (a–d: segment 7, e–h: segment 6). a (white arrows), e (white arrowheads) Plain phases. b, f
Arterial phases. c, g Portal phases. d, h Delayed phases. a, e Both tumors are isodense before contrast injections, (b, f) and show
hypoenhancement in the arterial phase. c, g In the portal venous phase, the tumor in segment 7 shows heterogeneous enhancement, and the
tumor in segment 6 shows central enhancement. d, h In the delayed phase, the tumor in segment 7 shows more heterogeneous enhancement,
and the tumor in segment 6 shows more central enhancement
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Fig. 4 The first needle biopsy. a The specimen shows marked sinusoidal dilatation with cystic cavity formation (hematoxylin and eosin staining,
×100). b Endothelial cells lining these spaces are flat, and no cellular atypia is identified. Liver cell plates are rather atrophic (hematoxylin and
eosin staining, ×400). c Immunostaining shows the endothelium of the portal vein (PV) and the hepatic artery (HA) as positive for CD34, but the
sinusoidal endothelium (arrows) is negative (×200). Intracytoplasmic granular staining of hepatocytes is nonspecific
Fig. 3 Abdominal contrast-enhanced magnetic resonance imaging (a–d: segment 7, e–h: segment 6). a (white arrows), e (white arrowheads) T1-
weighted image. b, f T2-weighted image. c, g Arterial phases on T1-weighted image. d, h Parenchymal phases on T1-weighted image. a, b, e,
and f Both liver tumors show the same intensity patterns on T1-weighted image and T2-weighted image. c, g However, in the arterial phase on
T1-weighted image, the tumor in segment 7 shows heterointensity, but the tumor in segment 6 shows central enhancement. d, h In the paren-
chymal phase of T1-weighted image, the tumor in segment 7 shows more heterointensity, and the tumor in segment 6 shows more
central enhancement
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[3]. Furthermore, recently PH was considered to be
related to HIV [4], immunosuppressive drugs after kid-
ney transplantation, and the administration of oral con-
traceptives [5]. In the present case, our patient had no
immunodeficiency diseases and, therefore, was not given
any immunosuppressive drugs. Furthermore, LH-RH
agonist injections have been shown to have an opposite
effect to oral contraceptives, which contain estrogen and
progestin; therefore there might be a causal relationship
between the two. However, there might be a relationship
between PH and prostate cancer as was previously re-
ported [9]. In the present case, the patient was asymp-
tomatic and had normal laboratory data. It is, therefore,
necessary to consider the typical symptoms and labora-
tory data for PH.
In general, the symptoms and the laboratory data in
PH depend on the disease processes. There is no typical
tumor marker of PH [8]. However, it is currently consid-
ered that PH is related to HIV infection [4], agents ad-
ministered after kidney transplantation [5, 10], and the
administration of oral contraceptives [6]. Furthermore,
PH is occasionally found in patients who have worsened
liver function [8]. Therefore, when faced with multiple
liver tumors accompanied by atypical radiological im-
ages, PH should be considered.
In imaging studies, various dynamic enhanced patterns
are characteristic. On dynamic contrast-enhanced ab-
dominal CT images, PH shows an isodense pattern be-
fore contrast injection; however, PH shows various
enhancement patterns after contrast injection [11–13].
Indeed, both of the tumors in this case showed hypoen-
hancement in the arterial phase. However, in the portal
venous phase, one showed heterogeneous enhancement,
and the other showed central enhancement. Further-
more, in the delayed phase, one showed more heteroge-
neous enhancement, and the other showed more central
enhancement. Abdominal MRI showed hypointense tu-
mors on T1WI and hyperintense tumors on T2WI in
both tumors. However, as in CT images, enhanced MRI
shows various enhanced patterns after contrast injection.
Fig. 6 The second needle biopsy. a The specimen shows almost the same findings as the previous biopsy (hematoxylin and eosin staining,
×100). b Although slight anisonucleosis and chromatin increase of dilated sinusoids-lining endothelium* was observed, there was no convincing
evidence of angiosarcoma (hematoxylin and eosin staining, ×400). c Sinusoidal endothelium (arrows) was negative for CD34 immunostaining. PV
portal vein
Fig. 5 Abdominal contrast-enhanced magnetic resonance imaging before the second tumor biopsy. a–c Some tumors show heterointensity, and
other tumors show central enhancement in the parenchymal phase of T1-weighted image
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Therefore, it is exceedingly difficult to accurately diag-
nose PH with only imaging studies [12, 13].
Histological information is necessary to accurately
diagnose PH. A parenchymal type and a phlebectatic
type have been reported among the histologic types [8].
The parenchymal type is characterized by the congestion
of irregular cavities that are neither lined by sinusoidal
cells nor fibrous tissue with the adjacent hepatic tissue
occasionally displaying liver cell necrosis [8]. The phle-
bectatic type is characterized by cavities lined by endo-
thelium. The present case is of the phlebectatic type.
CD34 is a useful marker of hematopoietic progenitor
cells and endothelial cells to distinguish hemangioma
from PH (CD34 positive and negative, respectively) [7].
As expected, the endothelium of this present case was
negative for CD34. Furthermore, the bacillary form of
PH is caused by infection, mostly occurring in immuno-
compromised cases. It contains clumps of organisms,
such as Bartonella henselae or Bartonella quintana,
which can be identified using the Warthin–Starry stain
[7]. No organisms were detected in the liver tissue in
this case. Various important findings can be obtained by
liver biopsy. However, because they could cause abdom-
inal bleeding, needle biopsies for PH should be per-
formed only in cases in which malignant disease cannot
be ruled out by other means [1].
There is no specific treatment for PH because it is not
a malignant tumor. Asymptomatic patients and those
who have progressive tumors may be conservatively
treated with regular follow-ups. Some lesions may
disappear spontaneously after withdrawal of possibly re-
lated chemicals and medications [7, 14]. In addition, in
patients with liver failure complications, liver transplant-
ation may be considered. But, especially with PH, as in
every case, the therapeutic options should always be
decided depending upon the patient’s condition and
situation.
Conclusions
PH is a rare hepatic benign tumor. However, PH should
be considered in cases presenting with multiple unknown
liver tumors that are revealed as atypical on radiological
images.
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